327 related articles for article (PubMed ID: 34279051)
41. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
42. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
43. Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease.
Cong J; Zhou P; Zhang R
Nutrients; 2022 May; 14(9):. PubMed ID: 35565943
[TBL] [Abstract][Full Text] [Related]
44. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
[TBL] [Abstract][Full Text] [Related]
45. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
[TBL] [Abstract][Full Text] [Related]
46. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.
Aragonès G; González-García S; Aguilar C; Richart C; Auguet T
Biomed Res Int; 2019; 2019():8507583. PubMed ID: 30719448
[TBL] [Abstract][Full Text] [Related]
47. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
48. Dietary fiber and the microbiota: A narrative review by a group of experts from the Asociación Mexicana de Gastroenterología.
Abreu Y Abreu AT; Milke-García MP; Argüello-Arévalo GA; Calderón-de la Barca AM; Carmona-Sánchez RI; Consuelo-Sánchez A; Coss-Adame E; García-Cedillo MF; Hernández-Rosiles V; Icaza-Chávez ME; Martínez-Medina JN; Morán-Ramos S; Ochoa-Ortiz E; Reyes-Apodaca M; Rivera-Flores RL; Zamarripa-Dorsey F; Zárate-Mondragón F; Vázquez-Frias R
Rev Gastroenterol Mex (Engl Ed); 2021; 86(3):287-304. PubMed ID: 34144942
[TBL] [Abstract][Full Text] [Related]
49. Gut microbiota-derived short-chain fatty acids and kidney diseases.
Li L; Ma L; Fu P
Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
[TBL] [Abstract][Full Text] [Related]
50. Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.
Tang Y; Du J; Wu H; Wang M; Liu S; Tao F
Curr Neuropharmacol; 2024; 22(2):191-203. PubMed ID: 36173071
[TBL] [Abstract][Full Text] [Related]
51. The Therapeutic Role of Short-Chain Fatty Acids Mediated Very Low-Calorie Ketogenic Diet-Gut Microbiota Relationships in Paediatric Inflammatory Bowel Diseases.
Alsharairi NA
Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235765
[TBL] [Abstract][Full Text] [Related]
52. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
53. Gut-derived short-chain fatty acids bridge cardiac and systemic metabolism and immunity in heart failure.
Wang A; Li Z; Sun Z; Zhang D; Ma X
J Nutr Biochem; 2023 Oct; 120():109370. PubMed ID: 37245797
[TBL] [Abstract][Full Text] [Related]
54. Biological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry.
Liu L; Li Q; Yang Y; Guo A
Front Vet Sci; 2021; 8():736739. PubMed ID: 34733901
[TBL] [Abstract][Full Text] [Related]
55. Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy.
Ziętek M; Celewicz Z; Szczuko M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33918804
[TBL] [Abstract][Full Text] [Related]
56. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
57. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
He X; Ji G; Jia W; Li H
Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
[TBL] [Abstract][Full Text] [Related]
58. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.
Kasubuchi M; Hasegawa S; Hiramatsu T; Ichimura A; Kimura I
Nutrients; 2015 Apr; 7(4):2839-49. PubMed ID: 25875123
[TBL] [Abstract][Full Text] [Related]
59. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease.
Qian XH; Xie RY; Liu XL; Chen SD; Tang HD
Aging Dis; 2022 Jul; 13(4):1252-1266. PubMed ID: 35855330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
